期刊文献+

环脂肽类抗生素达托霉素研究进展

The Latest Progresses on Daptomycin
原文传递
导出
摘要 对达托霉素的结构特点、抑菌原理、抗菌活性、临床应用进行综述,对其发展方向和前景进行探讨和展望,以期为达托霉素更深入研究与广泛应用提供参考。 To introduce the structure characteristics,antimicrobial mechanism and clinical application of daptomycin,discuss its developing direction and forecast its future in order to provide some help for more deep researches.
出处 《河北化工》 2012年第5期25-26,38,共3页 Hebei Chemical Industry
关键词 达托霉素 环脂肽 抗生素 抗菌活性 daptomycin cyclo-lipopetide antibiotic antibacterial activity
  • 相关文献

参考文献18

  • 1Baltz R H,M iao V,W rigley S K. Natural products to drug:dap tomycin and related lipopeptide antibiotics[J]. Nat Prod Rep, 2005,22(6) :717.
  • 2Thorne,Grace M, Alder,Jeff. Daptomycin: a novel lipopeptide antibiotic[J]. Clinical Microbiology Newslet ter, 2002,24(5) : 33.
  • 3Canepari P, M Boaretti, M del Mar Lie6, et al. Lipoteichoic acid as a new target for activity of antibiotics: mode of action ot" dapto mycin( L Y146032). Antimicrob [J]. Agents Chemother, 1990, 34:1 220.
  • 4Alborn WE J r, Allen NE, Preston DA. Daptomycin disrupt s membrane potential in growing Staphylococcus aureus[J]. Anti mierob Agents Chemother, 1991,35(11) : 2 282.
  • 5Silverman JA,Oliver N,Andrew T,et al. Resistance studies with iaptomycin[J]. Antimicrob Agzents Chemother,2001,45(6), 1 799.
  • 6Hill J ,Siedlecki J, Parr I, et al. Synthesis and biological activity of N-Acylated omit hine analogues of daptomycin[J]. Bioorg Med Chem Lett,2003,1;13(23):4 187.
  • 7Debono, M, M Barnhart, C B Carrell, et aL A complex of new a- cidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation[J]. Antibiot, 1987,40 : 761.
  • 8张石革.糖肽和环脂肽抗生素的进展与临床评价[J].中国医院用药评价与分析,2009,9(2):88-90. 被引量:4
  • 9Boaretti M,Canepari P. Identification of daptomycin binding pro- teins in the membrane of Enterococcus hirae[J]. Antimicrob A gents Chemother, 1995,39 : 2 068-2 072.
  • 10Canepari P,Boaretti M. Lipoteichoie acid as a target for antimi- crobial action[J]. Microb Drug Resist, 1996, (2) :85-89.

二级参考文献86

  • 1赵肖庆,郑捷.达托霉素在皮肤感染中的应用[J].世界临床药物,2005,26(3):171-174. 被引量:3
  • 2卜一珊,崔蓉.新的抗革兰阳性菌药物-达托霉素[J].中国药师,2005,8(7):594-596. 被引量:4
  • 3覃尚忠.达托霉素研究进展[J].中国药事,2006,20(6):375-377. 被引量:5
  • 4吴小林.治疗葡萄球菌感染的药物[J].国外医药(抗生素分册),2006,27(6):262-265. 被引量:3
  • 5Bailey J, Summers KM. Dalbavancin: a new lipoglycopeptide antibiotic[J]. Am J Health Syst Pharm ,2008,65(7) : 599.
  • 6Billeter M, Zervos MJ, Chen AY, et al. Dalbavancin : a novel once - weekly lipoglycopeptide antibiotic [J]. Clin Infect Dis, 2008,46(4) : 577.
  • 7Gales AC, Sader HS, Jones RN. Antimicrobial activity of dalbavancintested against gram - positive clinical isolates from Latin American medical centers [ J ]. Clin Microbiol Infect, 2005,11(2) :95.
  • 8Pace JL, Yang G. Glycopeptides: Update on an old successful antibiotic class [ J ]. Biochem Pharmacol, 2006,71 (7) : 968.
  • 9Streit JM, Fritsche TR, Sader HS, et al. Worldwide assessment of dalbavancinactivity and spectrum against over 6000 clinical isolates [ J ] . Clin Microbiol Infect, 2004,48 (2) : 137.
  • 10Jones RN, Stilwell MG, Sader HS, et al. Spectrum and potency of dalbavancin tested against 3322 Gram- positive cocci isolated in the United States Surveillance Program (2004) [J]. Diagn Microbiol Infect Dis ,2006,54(2) : 149.

共引文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部